Nurix Therapeutics Inc. (NRIX)
NASDAQ: NRIX
· Real-Time Price · USD
10.57
0.01 (0.09%)
At close: Aug 15, 2025, 3:59 PM
11.00
4.07%
After-hours: Aug 15, 2025, 05:17 PM EDT
Nurix Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
December - November.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | May 31, 2025 | Feb 28, 2025 | Nov 30, 2024 | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 |
Net Income | -207.32M | -208.4M | -193.57M | -176.98M | -165M | -144.73M | -143.95M | -148.71M | -157.44M | -178.56M | -180.36M | -171.34M | -154.47M | -135.45M | -117.19M | -99.41M | -89.09M | -55.13M |
Depreciation & Amortization | 17.67M | 16.67M | 16.43M | 15.88M | 15.12M | 14.36M | 13.65M | 12.93M | 12.44M | 11.73M | 10.81M | 11.82M | 9.68M | 7.69M | 6.08M | 2.68M | 2.48M | 2.33M |
Stock-Based Compensation | 36.37M | 34.83M | 33.93M | 33.45M | 33.14M | 33.01M | 33.67M | 33.95M | 32.49M | 30.54M | 28.13M | 24.68M | 22M | 19.17M | 15.8M | 13.49M | 10.29M | 6.83M |
Other Working Capital | -10.93M | -25.15M | -23.61M | 35.64M | 22.97M | 23.3M | 13.57M | -45.57M | -38.89M | -35.27M | -25.11M | -19.48M | -15.15M | -27.03M | 9.7M | 6.57M | 23.81M | 10.65M |
Other Non-Cash Items | -59.65M | 6.97M | 7.67M | 18.06M | 20.28M | 1.93M | 4.02M | -3.56M | -2.28M | -668K | 636K | 1.89M | 2.47M | 2.15M | 1.83M | 1.37M | 789K | 487K |
Deferred Income Tax | n/a | n/a | 930K | -7.96M | -7.96M | -7.96M | -8.89M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -2.25M | -22.22M | -18.4M | 35.03M | 22.95M | 23.59M | 15.18M | -40.62M | -36.39M | -28.68M | -19.02M | -19.81M | -16.11M | -28.61M | 9.11M | 7.93M | 25.42M | 12.48M |
Operating Cash Flow | -215.18M | -191.72M | -172.58M | -102.08M | -101.04M | -79.8M | -86.31M | -146.01M | -151.18M | -165.63M | -159.81M | -152.76M | -136.43M | -135.05M | -84.36M | -73.94M | -50.1M | -33M |
Capital Expenditures | -10.61M | -9.87M | -9.27M | -9.75M | -9.87M | -9.01M | -8.4M | -8.38M | -9.34M | -11.05M | -12.24M | -10.54M | -8.99M | -8.29M | -5.66M | -5.71M | -5.51M | -5.03M |
Cash Acquisitions | 38.4M | 38.4M | n/a | 88.49M | 24.86M | -20.05M | n/a | -146.06M | -61.17M | -14.28M | 4.06M | 61.63M | 1.98M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -606.38M | -763.33M | -707.95M | -498.13M | -442.9M | -278.5M | -246.33M | -184.85M | -242.69M | -246.76M | -239.37M | -303.14M | -245.29M | -316M | -348.5M | -391.97M | -428.82M | -303.91M |
Sales Maturities Of Investments | 551.87M | 505.51M | 459.51M | 376.62M | 365.61M | 375.25M | 323.04M | 330.92M | 303.86M | 261.05M | 278.81M | 249.35M | 240.79M | 258.46M | 245.91M | 201.38M | 142.19M | 71.57M |
Other Investing Acitivies | -38.4M | -167.53M | -129.13M | -217.62M | -153.99M | 20.05M | n/a | 146.06M | 61.17M | 14.28M | 39.44M | -53.79M | -4.5M | -57.54M | -102.59M | -190.59M | -286.63M | -232.34M |
Investing Cash Flow | -65.12M | -267.69M | -257.71M | -131.27M | -87.16M | 87.75M | 68.3M | 137.68M | 51.83M | 3.23M | 27.2M | -64.33M | -13.49M | -65.83M | -108.25M | -196.29M | -292.14M | -237.37M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 1.27M | n/a | n/a | n/a | -15K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -1K | -1K | -1K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 6.83M | 244.57M | 244.72M | 243.28M | 241.09M | 3.36M | 3.22M | 3.08M | 97.38M | 97.78M | 97.79M | 98.43M | 3.97M | 154.01M | 153.88M | 152.26M | 151.82M | 121.04M |
Financial Cash Flow | 247.77M | 485.52M | 485.67M | 290.09M | 246.03M | 8.3M | 8.16M | 3.08M | 116.78M | 117.19M | 117.19M | 117.83M | 3.97M | 154.01M | 153.88M | 152.26M | 371.12M | 340.34M |
Net Cash Flow | -32.53M | 26.1M | 55.37M | 56.74M | 57.83M | 16.24M | -9.85M | -5.25M | 17.43M | -45.21M | -15.42M | -99.27M | -145.94M | -46.87M | -38.73M | -117.97M | 28.88M | 69.97M |
Free Cash Flow | -225.79M | -201.59M | -181.86M | -111.84M | -110.91M | -88.81M | -94.71M | -154.39M | -160.52M | -176.68M | -172.05M | -163.3M | -145.41M | -143.34M | -90.03M | -79.64M | -55.62M | -38.03M |